Antisense c-myc inhibition of lymphoma growth.
Wickstrom
E
E
Department of Microbiology and Immunology, Thomas Jefferson University, Philadelphia, PA 19107, USA.
D000818:Animals; D000970:Antineoplastic Agents / Q000494:pharmacology / Q000627:therapeutic use*; D001483:Base Sequence; D002051:Burkitt Lymphoma / Q000188:drug therapy / Q000235:genetics / Q000517:prevention & control*; D004354:Drug Screening Assays, Antitumor; D004742:Enhancer Elements, Genetic; D005813:Genes, Synthetic; D016259:Genes, myc; D007075:Immunoglobulin M / Q000235:genetics; D051379:Mice; D008822:Mice, Transgenic; D008957:Models, Genetic; D009363:Neoplasm Proteins / Q000096:biosynthesis / Q000235:genetics*; D016376:Oligonucleotides, Antisense / Q000235:genetics / Q000494:pharmacology / Q000627:therapeutic use*; D016271:Proto-Oncogene Proteins c-myc / Q000096:biosynthesis; D011993:Recombinant Fusion Proteins / Q000096:biosynthesis / Q000235:genetics
D000970:Antineoplastic Agents; D007075:Immunoglobulin M; D009363:Neoplasm Proteins; D016376:Oligonucleotides, Antisense; D016271:Proto-Oncogene Proteins c-myc; D011993:Recombinant Fusion Proteins